focus
Previous article:
Walensky prepares to leave CDC — and Congress — behind
Next article: Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
Next article: Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
hotspot
hotspot
-
White House drug shortage group privately met with industry
2025-09-27 12:44 -
Biotech venture capitalists face new demands from investors
2025-09-27 12:28 -
NIH director takes cautious approach to Biden drug pricing priority
2025-09-27 12:11 -
TytoCare raises $49 million to build out AI
2025-09-27 11:12 -
AI generated plenty of interest at JPM but not a lot of trust
2025-09-27 11:07 -
What the cancer research community can learn from the Covid response
2025-09-27 10:32